BiotechTube
Home/jCyte/John Sholar
JS

John Sholar

Chief Executive Officer

jCyte

Therapeutic Areas

OphthalmologyRetinal DiseasesGenetic Disorders

jCyte Pipeline

DrugIndicationPhase
jCellRetinitis PigmentosaPhase 3
jCell (RPCs)Diabetic RetinopathyPreclinical

Leadership Team at jCyte

HJ
Henry J. Klassen
Co-Founder and Chairman
JY
Jing Yang
Co-Founder and Chief Science Officer
AM
Adrian Morris
Chief Development Officer
RB
Rob Beathard
Chief Strategy Officer
View full jCyte profile